Cash and cash equivalents

Qudian Inc. Reports First Quarter 2021 Unaudited Financial Results

Retrieved on: 
Tuesday, June 15, 2021
Balance sheet, Companies, Xiamen, Opera, New York Stock Exchange, Cash and cash equivalents, Draft:Qudian

XIAMEN, China, June 15, 2021 /PRNewswire/ --Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a leading technology platform empowering the enhancement of online consumer finance experience in China, today announced its unaudited financial results for the quarter ended March 31, 2021.

Key Points: 
  • XIAMEN, China, June 15, 2021 /PRNewswire/ --Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a leading technology platform empowering the enhancement of online consumer finance experience in China, today announced its unaudited financial results for the quarter ended March 31, 2021.
  • "We are delighted to officially launch our first WLM KIDS activities center in January in Xiamen.
  • Income from operationswas RMB464.8 million(US$70.9 million), as compared to aloss of RMB961.1 million for the first quarter of 2020.
  • As of March 31, 2021, the Company had cash and cash equivalents ofRMB2,187.5 million(US$333.9 million) and restricted cash ofRMB234.1million(US$35.7million).

Nyxoah Issues First Quarter 2021 Results

Retrieved on: 
Thursday, June 10, 2021
Asset, Cash, Cash and cash equivalents

Cost of goods sold was 52,000 for the three months ended March 31, 2021, compared to no cost for the three months ended March 31, 2020.

Key Points: 
  • Cost of goods sold was 52,000 for the three months ended March 31, 2021, compared to no cost for the three months ended March 31, 2020.
  • Cash and cash equivalents totaled 86.2 million on March 31, 2021, as compared to 92.3 million on December 31, 2020.
  • The decrease was due to a lack of capital increase during the first quarter of 2021.
  • In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods.

Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2021

Retrieved on: 
Thursday, June 10, 2021
Financial accounting, Fiscal year, Cash and cash equivalents

We expect to present interim results from this study at a medical or scientific conference in the Fall of 2021.

Key Points: 
  • We expect to present interim results from this study at a medical or scientific conference in the Fall of 2021.
  • Research and development expenses for the fiscal year ended March 31, 2021 were $12.6 million, compared to $10.6 million for the fiscal year ended March 31, 2020.
  • General and administrative expenses for the fiscal year ended March 31, 2021 were $10.5 million, compared to $8.9 million for the fiscal year ended March 31, 2020.
  • Additionally, as previously reported, the Company had cash, cash equivalents, and restricted cash of $34.9 million as of April 30, 2021.

DGAP-News: Fabasoft AG - fiscal year 2020/2021 at a glance

Retrieved on: 
Wednesday, June 9, 2021
Asset, Cash, Cash and cash equivalents

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • - Cash flows from operating activities: EUR 21.0 million (EUR 14.1 million in the fiscal year 2019/2020)
    - Cash and cash equivalents: EUR 48.4 million as of 31 March 2021 (EUR 35.1 million as of 31 March 2020)
    The Company's Annual Report and the Annual Financial Report can be accessed using the following links:

Trading Statement for the three months to 31 March 2021

Retrieved on: 
Wednesday, June 9, 2021
Asset, Cash, Cash and cash equivalents

Total commercial revenues rose by 13% to $1.9m for the period vs $1.7m for the three months to end March 2020.

Key Points: 
  • Total commercial revenues rose by 13% to $1.9m for the period vs $1.7m for the three months to end March 2020.
  • The Key Financials & KPI Highlights included in this trading update exclude the contribution from Port Akdeniz.
  • At the end of March 2020, GPH had cash and cash equivalents of $170.7m, compared to $99.5m at 31 December 2020.
  • Global Ports Holding will provide a detailed update on current trading and outlook when it reports audited financial results for the 15 months to end March 2021 in July 2021.

D-BOX Technologies Reports Fourth Quarter and Fiscal Year 2021 Results

Retrieved on: 
Monday, June 7, 2021
Asset, Cash, Cash and cash equivalents, Electronic Arts, Articles, Video game companies, Companies

LONGUEUIL, Quebec, June 07, 2021 (GLOBE NEWSWIRE) -- D-BOX Technologies Inc. (TSX:DBO), a world leader in immersive entertainment experiences, today announced results for the fiscal year and fourth quarter ended March 31, 2021.

Key Points: 
  • LONGUEUIL, Quebec, June 07, 2021 (GLOBE NEWSWIRE) -- D-BOX Technologies Inc. (TSX:DBO), a world leader in immersive entertainment experiences, today announced results for the fiscal year and fourth quarter ended March 31, 2021.
  • During the fourth quarter, we are pleased to get the support from the investment community with the completion of $5.75M equity financing.
  • Highlights for the Fiscal Year ended March 31, 2021
    Cash and cash equivalents were $9.1 million as of March 31, 2021 compared to $4.1 million as of March 31, 2020.
  • Net loss was $2.5 million compared to a net loss of $3.1 million during the same period last year.

Intrepid Announces Payoff of Senior Notes; Updates Cash Position

Retrieved on: 
Wednesday, June 2, 2021
Intrepid Potash, Cash and cash equivalents, Paycheck Protection Program

Denver, CO, June 02, 2021 (GLOBE NEWSWIRE) -- Intrepid Potash Inc. (NYSE:IPI) (Intrepid) today announced the following updates to its liquidity position:

Key Points: 
  • Denver, CO, June 02, 2021 (GLOBE NEWSWIRE) -- Intrepid Potash Inc. (NYSE:IPI) (Intrepid) today announced the following updates to its liquidity position:
    On June 1, 2021, Intrepid paid down the remaining $15 million outstanding on its Series B Senior Notes with cash on hand.
  • Along with the paydown, Intrepid made a make-whole payment of $0.5 million and paid accrued interest of $0.1 million to noteholders.
  • After the payoff of its Senior Notes, Intrepid has cash and cash equivalents of approximately $47 million and outstanding debt of $30 million on its revolving credit facility and $10 million outstanding on its PPP loan, which it expects to be forgiven, for total outstanding debt of $40 million.
  • Rising prices, strong fertilizer sales, improving oil and gas fundamentals, and prudent capital spending have improved our net debt position to the point where we now have more cash on hand than outstanding debt.

Glory Star Restates its 2020 Financial Results

Retrieved on: 
Wednesday, June 2, 2021
Money, Economy, Finance, Corporate finance, Asset, Cash, Cash and cash equivalents, Cash flow, Investment

As a result, the Company's net income increased to $49.0 million from $26.4 million in 2019, representing an increase of 85.4% year over year.

Key Points: 
  • As a result, the Company's net income increased to $49.0 million from $26.4 million in 2019, representing an increase of 85.4% year over year.
  • The Company's basic earnings per share increased to $0.91 from $0.64 in 2019, representing an increase of 42.2% year over year.
  • The Restatement had no impact on the Company's cash and cash equivalents, or cash flows from operating, investing and financing activities.
  • Glory Star New Media Group Holdings Limited is a leading digital media platform and content-driven e-commerce company in China.

Ascendis Pharma A/S Reports First Quarter 2021 Financial Results

Retrieved on: 
Thursday, May 27, 2021
Clinical research, Design of experiments, Health sciences, Medical research, Health, Clinical trials, Asset, Cash, Cash and cash equivalents, Placebo-controlled study

Continued execution in the ongoing North American and European phase 3 PaTHway Trial in adults with HP with topline results expected in the fourth quarter of 2021.

Key Points: 
  • Continued execution in the ongoing North American and European phase 3 PaTHway Trial in adults with HP with topline results expected in the fourth quarter of 2021.
  • On track for clinical program update on both randomized, double-blind, placebo-controlled trials expected in the fourth quarter of 2021.
  • As of March 31, 2021, Ascendis Pharma had cash, cash equivalents and marketable securities of 771.1 million compared to 834.1 million as of December 31, 2020.
  • As of March 31, 2021, Ascendis Pharma had 53,829,379 ordinary shares outstanding.

Discovery Reports Q1 2021 Financial Results and Update

Retrieved on: 
Thursday, May 27, 2021
Balance sheet, Asset, Cash, Cash and cash equivalents, OTC Markets Group, Companies, BlackBerry Limited

TORONTO, May 27, 2021 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX-V: DSV, OTCQX: DSVSF) (Discovery or the Company) is pleased to announce its financial results for the three months ended March 31, 2021 (Q1 2021), and to provide a summary of key events for the quarter and subsequent to quarter-end.

Key Points: 
  • TORONTO, May 27, 2021 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX-V: DSV, OTCQX: DSVSF) (Discovery or the Company) is pleased to announce its financial results for the three months ended March 31, 2021 (Q1 2021), and to provide a summary of key events for the quarter and subsequent to quarter-end.
  • HIGHLIGHTS FROM Q1 2021 & SUBSEQUENT EVENTS:
    As at March 31, 2021, we had a cash and cash equivalents and short term investment balance of $94.7 million.
  • The exercises resulted in gross proceeds of approximately $31 million, of which approximately $17.6 million was received in 2021.
  • The following selected financial data is summarized from the Companys condensed interim consolidated financial statements and related notes thereto (the Financial Statements) for the three months ended March 31, 2021.